| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/10/2002 | WO2001072959A3 Plastid transformation vectors for expressing human proteins in plants |
| 05/10/2002 | WO2001070808A3 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 05/10/2002 | WO2001068677A3 Derivatives of breast canacer antigen her-2 for therapeutical use |
| 05/10/2002 | WO2001066778A3 Production of foreign polypeptides in plants as viral coat protein fusions |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066573A3 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 05/10/2002 | WO2001064891A3 Nucleotide sequences for embryo and/or endosperm specific expression in plants |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001062779A3 New transcription factor carp-2 |
| 05/10/2002 | WO2001057234A3 Biopolymer thickener |
| 05/10/2002 | WO2001055339A3 Novel fetal nucleic acids and polypeptides |
| 05/10/2002 | WO2001055323A3 Nucleic acids, proteins, and antibodies |
| 05/10/2002 | WO2001048182A3 Amino acid inducible expression system |
| 05/10/2002 | WO2001048015A3 G protein-coupled receptors |
| 05/10/2002 | WO2001047963A3 Inhibitors of complement activation, their preparation and use |
| 05/10/2002 | WO2001047962A3 Attenuated microorganisms for the treatment of infection |
| 05/10/2002 | WO2001047955A3 Improvements in or relating to immune responses to hiv |
| 05/10/2002 | WO2001046455A3 Survivin promotion of angiogenesis |
| 05/10/2002 | WO2001046420A3 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 05/10/2002 | WO2001046213A3 Compound comprising a peptide moiety and an organo-silane moiety. |
| 05/10/2002 | WO2001042781A3 Supracolonic aerodigestive neoplasm detection |
| 05/10/2002 | WO2001042472A3 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 05/10/2002 | WO2001042451A3 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 05/10/2002 | WO2001042423A3 Compositions and methods for detecting stress-inducible proteins |
| 05/10/2002 | WO2001042296A3 Clasp-5 transmembrane protein |
| 05/10/2002 | WO2001042284A3 Protein comprising ig-like domain 4 of a vegf receptor mediates receptor dimerization, but not activation |
| 05/10/2002 | WO2001040466A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/10/2002 | WO2001040142A3 P21 derived peptides capable of inhibiting cdk/cyclin complexes |
| 05/10/2002 | WO2001038351A3 Nucleotide sequence of the shrimp white spot syndrome bacilliformvirus (wsbv), systems containing this sequence and detection kits |
| 05/10/2002 | WO2001038349A3 NOVEL ss-DEFENSINS |
| 05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
| 05/10/2002 | WO2001036618A3 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
| 05/10/2002 | WO2001036467A3 Mammalian receptor proteins; related reagents and methods |
| 05/10/2002 | WO2001036446A3 Use of g-protein coupled receptors (gpcrs) and modified gpcrs for the treatment of diseases |
| 05/10/2002 | WO2001036433A3 Synthetic lipid-a analogs and uses thereof |
| 05/10/2002 | WO2001036432A3 18 human secreted proteins |
| 05/10/2002 | WO2001034810A3 Genes essential for microbial proliferation |
| 05/10/2002 | WO2001034641A8 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 05/10/2002 | WO2001033944A9 Compositions and methods for modulation of plant cell division |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001031007A9 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/10/2002 | WO2001030972A3 Regulation of gene expression by neuroleptic agents |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2001026643A9 Inhibition of tumorigenic properties of melanoma cells |
| 05/10/2002 | WO2001025797A3 Methods of evaluating whether a test agent is an agent affecting a leptin receptor |
| 05/10/2002 | WO2001025271A3 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 05/10/2002 | WO2001023533A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 05/10/2002 | WO2001021203A9 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 05/10/2002 | WO2001019859A3 LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS δ-ENDOTOXIN COMPOSITIONS AND METHODS OF USE |
| 05/10/2002 | WO2001014420A3 Novel members of the plexin family and uses thereof |
| 05/10/2002 | WO2001000877A3 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 05/10/2002 | WO2000078968A3 Nucleotide sequences of moraxella catarrhalis genome |
| 05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | CA2783639A1 Active variants of fgf with improved specificity |
| 05/10/2002 | CA2463623A1 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 05/10/2002 | CA2428606A1 Novel targeted compositions for diagnostic and therapeutic use |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427858A1 Compositions for inhibiting grb7 |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427809A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427701A1 Human 7tm proteins and polynucleotides encoding the same |
| 05/10/2002 | CA2427659A1 Methods for producing and improving therapeutic potency of binding polypeptides |
| 05/10/2002 | CA2427629A1 Gene regulation therapy involving ferritin |
| 05/10/2002 | CA2427602A1 Detection of infectious agents using antigen mimics |
| 05/10/2002 | CA2427572A1 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | CA2427539A1 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | CA2427436A1 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | CA2427257A1 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | CA2427163A1 Influenza virus vector for infection of dendritic cells |
| 05/10/2002 | CA2426200A1 Inhibition or reversal of skin aging by actin-sequestering peptides |
| 05/10/2002 | CA2426121A1 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/10/2002 | CA2426012A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 05/10/2002 | CA2425842A1 Use of il-1 inhibitors and tnf antagonists, partially in combination with recombinant erythropoietins, for the treatment of anemia |
| 05/10/2002 | CA2425583A1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 05/10/2002 | CA2424932A1 Cd36 as a heat shock protein receptor and uses thereof |
| 05/09/2002 | US20020056153 Regulatory sequences for use in the control of expression of heterologous gene; for use as tools in genetic engineering |
| 05/09/2002 | US20020056152 Nucleotide sequences coding polypeptide; for use geenration of disease resistant plants |
| 05/09/2002 | US20020056151 Polypeptide for use as an insecticide; for generation of disease resistant plants |
| 05/09/2002 | US20020056146 Expression vector for use in generation of trangenic animals; for use in animal modeling of disease |
| 05/09/2002 | US20020056144 Transgenic animal models for cardiac hypertrophy and methods of use thereof (screening) |
| 05/09/2002 | US20020055627 Nucleotide sequences coding cancer antigens for use in the detection treatment and prevention of cancer of colon and/or rectum |
| 05/09/2002 | US20020055626 Nucleotide sequences coding membrane proteins for use in drug screening and treatment of physiological defects |
| 05/09/2002 | US20020055625 Members of TNF and TNFR families |
| 05/09/2002 | US20020055624 Polypeptide for use in the treatment of inflammation, graft vs host disease, sepsis, tumors and metastasis |
| 05/09/2002 | US20020055622 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders |
| 05/09/2002 | US20020055618 Methods and substances for preventing and treating autoimmune disease |
| 05/09/2002 | US20020055617 Cloning and recombinant production of cfr receptor(s) |
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055492 Recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. |
| 05/09/2002 | US20020055482 Molecular constructs with a carcinoembryonic antigen (cea) transcriptional regulatory sequence |
| 05/09/2002 | US20020055481 DNA that represents the splicing enhancer sequence (SES) in exon 45 of human dystrophin gene, and serves as a template in preparation of the antisense oligonucleotide, which is used to induce exon 45 skipping |
| 05/09/2002 | US20020055480 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/09/2002 | US20020055478 Monitoring 103P3E8 gene products in a biological sample from a patient who has or who is suspected of having cancer and comparing the gene expression products with that of a normal sample |